RNA5SP187: A Potential Drug Target and Biomarker (G100873449)

Target Name: RNA5SP187

NCBI ID: G100873449

RNA5SP187

Other Name(s): RNA, 5S ribosomal pseudogene 187 | RNA, 5S ribosomal 187 | RN5S187

RNA5SP187: A Potential Drug Target and Biomarker

RNA5SP187 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a 24.8 kilobase (kb) RNA molecule that is expressed in various tissues and cells in the human body. RNA5SP187 has been shown to play a role in the regulation of cell proliferation, apoptosis, and tissue repair.

The Potential Role of RNA5SP187 as a Drug Target

RNA5SP187 has been shown to be a good candidate for drug targeting due to its unique structure and its expression pattern in different tissues and cells. It is highly expressed in the brain, heart, and liver, and its levels are decreased in various diseases, such as cancer, neurodegenerative diseases, and autoimmune diseases.

One of the key features of RNA5SP187 is its nuclear export, which allows it to leave the nucleus and enter the cytoplasm. This property makes RNA5SP187 a potential drug target because it can be easily targeted by small molecules or antibodies. Additionally, its expression pattern in different tissues and cells makes it a good biomarker for disease diagnosis and monitoring.

The Potential Role of RNA5SP187 as a Biomarker

RNA5SP187 has also been shown to be a potential biomarker for various diseases. For example, it has been shown to be downregulated in various cancer types, including breast, ovarian, and prostate cancer. This suggests that RNA5SP187 may be a useful biomarker for cancer diagnosis and treatment.

In addition, RNA5SP187 has also been shown to be downregulated in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that RNA5SP187 may be a useful biomarker for these diseases and could be a potential target for new therapies.

RNA5SP187 has also been shown to be downregulated in autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. This suggests that RNA5SP187 may be a useful biomarker for these diseases and could be a potential target for new therapies.

Conclusion

In conclusion, RNA5SP187 is a non-coding RNA molecule that has been shown to play a role in the regulation of cell proliferation, apoptosis, and tissue repair. Its unique structure and high expression pattern in different tissues make it a potential drug target and biomarker. Further research is needed to fully understand the role of RNA5SP187 in disease and to develop new treatments based on it.

Protein Name: RNA, 5S Ribosomal Pseudogene 187

The "RNA5SP187 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP187 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets